Galera Therapeutics, Inc. (GRTX) › Cash & EquivalentsGalera Therapeutics, Inc. (GRTX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $14.81M2019: $18.36M2020: $15.87M2021: $19.86M2022: $4.27M2023: $18.26M2024: $8.29M2025: $6.38M$6.38M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$6.38M-23.1%2024$8.29M-54.6%2023$18.26M+328.0%2022$4.27M-78.5%2021$19.86M+25.1%2020$15.87M-13.5%2019$18.36M+23.9%2018$14.81M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share